News

As companies across the globe are speeding up to bring an effective COVID vaccine, Bharat Biotech’s Joint Managing Director Suchitra Ella hinted that India’s indigenous Covaxin in the country is likely to be available in the first quarter of...

Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Inrebic® (fedratinib) for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with...

Some of the country's initial 30,000 doses of the Pfizer-BioNTech vaccines touched down on Sunday night, Prime Minister Justin Trudeau announced on Twitter, sharing a photo of a plane being unloaded. "This is good news," he said. "But our fight...

Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients with COVID-19 did not meet its primary endpoint. Initial data show there was no...

Saudi Arabia approved the use of the Pfizer-BioNTech novel coronavirus vaccine, state media reported, becoming the second Gulf country after Bahrain to green-light the drug. "The Saudi Food and Drug Authority (SFDA) has approved the registration of Pfizer-BioNTech Covid-19 vaccine...

ERT, a global leader in clinical end-point data solutions, announced that Bioclinica, a technological and scientific leader in clinical imaging, has agreed to merge with ERT. This combination will create a leading partner to global pharmaceutical and biotechnology companies,...

As the various COVID-19 vaccines move closer to the finish line, their developers have been raising money from investors or through advance government purchases to ramp up manufacturing. Now, a Chinese company has done the same for its candidate. Sinovac...